Graham Doyle

Stock Analyst at UBS

(2.05)
# 3,039
Out of 4,996 analysts
11
Total ratings
60%
Success rate
4.64%
Average return

Stocks Rated by Graham Doyle

Fresenius Medical Care AG
Sep 2, 2025
Downgrades: Sell
Price Target: n/a
Current: $25.58
Upside: -
GE HealthCare Technologies
May 5, 2025
Upgrades: Neutral
Price Target: $74$73
Current: $72.46
Upside: +0.75%
Smith & Nephew
Mar 12, 2025
Downgrades: Neutral
Price Target: n/a
Current: $35.42
Upside: -
Koninklijke Philips
Feb 20, 2025
Upgrades: Buy
Price Target: n/a
Current: $26.82
Upside: -